The AiriCU series is a medical mesh nebulizer that can be used in combination with a ventilator for the nebulization of aerosols.
It facilitates the administration of medication at all stages of the patient's respiratory process(invasive mechanical ventilation, invasive ventilation, high flow, and self-ventilation).
Our technology
AiMesh is feellife's core nebulization technology patent matrix, as well as an internationally certified invention patent. By combining artificial intelligence algorithms with feellife's unique nebulizer sheet polymer material, AiMesh redefines the nebulization industry.
Critical Care Nebulization Expert
With the vision of "The Third Way of Dosing" and the technology core of "AiMesh ®" polymer nebulizer, feellife owns more than 250+ international invention patents and certificates, taking the leading position in the field of nebulized drug delivery, and the clinical nebulization equipment for hospital intensive care represented by "AirICU" has already benefited millions of patients in more than 40 countries and regions.
50+
Doctors Recommended
10m
Patients Used
250 +
International Patents
4+
Core Technology Inside
Introduction Chronic obstructive pulmonary disease (COPD) is a progressive lung condition resulting from damage caused by harmful chemicals. These chemicals trigger a series of inflammatory responses that not only harm lung structure but also increase mucus production in the airways. COPD is characterized as a partially reversible condition with restricted airflow, leading to permanent damage […]
Due to the characteristics of the lung tissue itself, the speed of lung absorption is very fast, no less than intravenous injection, such as isoproterenol aerosol can play a role in asthma 1-2min after inhalation.
Aerosol administration during noninvasive ventilation (NIV) is a common clinical drug administration method, but the drug administration efficiency of different drug delivery devices is different.
Together we make the world better
